These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19364169)

  • 41. Venomous snakebite in mountainous terrain: prevention and management.
    Boyd JJ; Agazzi G; Svajda D; Morgan AJ; Ferrandis S; Norris RL
    Wilderness Environ Med; 2007; 18(3):190-202. PubMed ID: 17896851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Venomous Snake Bite in India - Why do 50,000 Indians Die Every Year?
    Menon JC; Joseph JK; Whitaker RE
    J Assoc Physicians India; 2017 Aug; 65(8):78-81. PubMed ID: 28799310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries.
    Patikorn C; Ismail AK; Abidin SAZ; Blanco FB; Blessmann J; Choumlivong K; Comandante JD; Doan UV; Mohamed Ismail Z; Khine YY; Maharani T; Nwe MT; Qamruddin RM; Safferi RS; Santamaria E; Tiglao PJG; Trakulsrichai S; Vasaruchapong T; Chaiyakunapruk N; Taychakhoonavudh S; Othman I
    BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35296460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy of low-dose antivenom therapy on morbidity and mortality in snakebite cases.
    Açikalin A; Gökel Y; Kuvandik G; Duru M; Köseoğlu Z; Satar S
    Am J Emerg Med; 2008 May; 26(4):402-7. PubMed ID: 18410806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Snake venoms and antivenoms: critical supply issues.
    Bawaskar HS
    J Assoc Physicians India; 2004 Jan; 52():11-3. PubMed ID: 15633710
    [No Abstract]   [Full Text] [Related]  

  • 46. Estimating the global burden of snakebite can help to improve management.
    Chippaux JP
    PLoS Med; 2008 Nov; 5(11):e221. PubMed ID: 18986211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study of snake bite cases at Liaquat University Hospital Hyderabad/Jamshoro.
    Hayat AS; Khan AH; Shaikh TZ; Ghouri RA; Shaikh N
    J Ayub Med Coll Abbottabad; 2008; 20(3):125-7. PubMed ID: 19610536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Participatory approaches and open data on venomous snakes: A neglected opportunity in the global snakebite crisis?
    Geneviève LD; Ray N; Chappuis F; Alcoba G; Mondardini MR; Bolon I; Ruiz de Castañeda R
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006162. PubMed ID: 29518075
    [No Abstract]   [Full Text] [Related]  

  • 49. The neglected burden of snakebites in Cameroon: a review of the epidemiology, management and public health challenges.
    Tochie JN; Temgoua MN; Njim T; Celestin D; Tankeu R; Nkemngu NJ
    BMC Res Notes; 2017 Aug; 10(1):405. PubMed ID: 28807018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in snakebite envenomation therapy: scientific, technological and public health considerations.
    Gutiérrez JM; Lomonte B; León G; Rucavado A; Chaves F; Angulo Y
    Curr Pharm Des; 2007; 13(28):2935-50. PubMed ID: 17979738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Standardization of regional reference for mamushi (Gloydius blomhoffii) antivenom in Japan, Korea, and China.
    Fukuda T; Iwaki M; Hong SH; Oh HJ; Wei Z; Morokuma K; Ohkuma K; Dianliang L; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2006 Feb; 59(1):20-4. PubMed ID: 16495629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rediscovery of severe saw-scaled viper (Echis sochureki) envenoming in the Thar desert region of Rajasthan, India.
    Kochar DK; Tanwar PD; Norris RL; Sabir M; Nayak KC; Agrawal TD; Purohit VP; Kochar A; Simpson ID
    Wilderness Environ Med; 2007; 18(2):75-85. PubMed ID: 17590073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product--'what's in a name?'.
    Warrell DA
    Trans R Soc Trop Med Hyg; 2008 May; 102(5):397-9. PubMed ID: 18359053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating the Burden of Snakebite on Public Hospitals in KwaZulu Natal, South Africa.
    Darryl W; Sartorius B; Hift R
    Wilderness Environ Med; 2016 Mar; 27(1):53-61. PubMed ID: 26948554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Snake venoms and coagulopathy.
    White J
    Toxicon; 2005 Jun; 45(8):951-67. PubMed ID: 15922768
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Snakebite: a forgotten problem.
    Bhaumik S
    BMJ; 2013 Jan; 346():f628. PubMed ID: 23369843
    [No Abstract]   [Full Text] [Related]  

  • 57. Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes.
    Suchithra N; Pappachan JM; Sujathan P
    Emerg Med J; 2008 Apr; 25(4):200-4. PubMed ID: 18356348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An audit of snake bite injuries seen at the Usmanu Danfodiyo University Teaching Hospital Sokoto, Nigeria.
    Njoku CH; Isezuo SA; Makusidi MA
    Niger Postgrad Med J; 2008 Jun; 15(2):112-5. PubMed ID: 18575483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Snake serum becoming scarce. The churches also issue warning].
    Peters M
    MMW Fortschr Med; 2002 Oct; 144(40):15. PubMed ID: 12440287
    [No Abstract]   [Full Text] [Related]  

  • 60. Snake venoms and their toxins: an Australian perspective.
    Hodgson WC; Wickramaratna JC
    Toxicon; 2006 Dec; 48(7):931-40. PubMed ID: 16920171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.